RxDoctor Payments Data

Amy Friggle, PA

Physician Assistant · Salt Lake City, UTNPI 1336339712

Payments from drug & device makers

$681in general payments, 2019–2025

Across 17 payments — averaging $40.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$236
  • AbbVie$185
  • Biohaven Pharmaceuticals, Inc.$63
  • Pfizer$59
  • Bayer$34
  • Antares Pharma, Inc.$22
  • plus $82 from 5 others

What the payments were for

  • Food & beverage$681100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$681 in reported general payments places this provider in the 65th percentile of 1,543 physician assistant providers in Utah.

See all physician assistant providers in Utah

Medicare billing

Part B allowed, 2024
$81,307
Medicare patients
141
Services billed
834

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron32$17,315
EliquisApixaban25$15,656
JardianceEmpagliflozin17$9,649
XareltoRivaroxaban19$6,120
Duloxetine Hcl27$1,717
Estradiol13$1,407
Lantus SolostarInsulin Glargine,hum.Rec.Anlog15$1,406
Sertraline Hcl66$1,252
Ultra-Fine Nano Pen NeedlePen Needle, Diabetic13$1,244
Levothyroxine Sodium102$1,160
Atorvastatin Calcium69$1,112
Donepezil Hcl35$1,059
Ondansetron OdtOndansetron15$925
Potassium Chloride50$893
Olanzapine17$882

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$59$15,65625 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,543 physician assistant providers in Utah.

Other physician assistant in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →